Similar companies
| Company | Revenue | |
|---|---|---|
 |
Encompass HealthEHC |
1.3B 1.6% |
 |
Brookdale Senior LivingBKD |
778M 7.8% |
 |
DaVitaDVA |
3.19B 3.8% |
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Revenue | 591M | 3.5% |
| Gross Profit | -77M | 20% |
| Cost of Revenue | 668M | 0.1% |
| Operating expense | 212M | 2.9% |
| Net Income | 32M | 124.3% |
| EBITDA | 61M | 55.4% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 2.12B | 1.3% |
| Total Liabilities | 938M | 0.9% |
| Total Equity | 1.13B | 3.4% |
| Shares Outstanding | 33M | 0.2% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | 52M | 899.6% |
| Cash from investing | -1.6M | 48.8% |
| Cash from financing | -14M | 64.7% |
EPS
Financial Highlights for Amedisys in Q2 '24
Amedisys reported a revenue of 591M, which is a 3.5% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at -77M, marking a 20% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 668M, a 0.1% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 212M, showing a -2.9% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 32M, showing a 124.3% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 61M, showing a 55.4% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Amedisys with growth in revenue, gross profit, and net income.
